Insight

Beverly A. Zavaleta: Mouth Sores and Cancer Treatment Survey

healthline.com

Oct 29, 2024, 17:57

Beverly A. Zavaleta: Mouth Sores and Cancer Treatment Survey

Beverly A. Zavaleta, Physician Advisor at Tenet Healthcare, shared a post on X:

“If you (or did) suffer with mucositis (mouth sores) from chemotherapy, please help us understand this better by completing a survey created by Make Cancer Less Shitty.”

Beverly A. Zavaleta cancer chemotherapy Make Cancer Less Shitty mouth sores mucositis OncoDaily Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Insight

Jan 16, 2025, 09:37

Laura Bukavina: Age doesn't limit EV efficacy

Blog

Jan 16, 2025, 09:28

Glenn J. Hanna: Multidisciplinary approach to treat HPV-driven oropharyngeal cancer

Societies

Jan 16, 2025, 09:23

A look back on 2024 MCI Precision Oncology - Miami Cancer Institute Research

Societies

Jan 16, 2025, 09:17

MD Anderson has received a $10 million gift to support Be Well Beaumont initiative

Science

Jan 16, 2025, 09:12

Erman Akkus: TACE plus+ treatments in Hepato-Cellular Carcinoma

Dialogues

Jan 16, 2025, 09:08

Hope, Research, and Advocacy: Paving the Way to a Cure

Insight

Jan 16, 2025, 08:54

Financial Toxicity in Oncology: Impact and Proposed Solutions in JCO Oncology Practice

Insight

Jan 16, 2025, 08:49

EORTC meta-analysis: Progression-free survival as surrogate in advanced cervical carcinoma

Insight

Jan 16, 2025, 08:42

Hidehito Horinouchi: Telisotuzumab Vedotin and Osimertinib in EGFR-Mutated NSCLC

Career

Jan 16, 2025, 08:14

Narjust Florez was named as a health equity champion by Boston Business Journal

Blog

Jan 16, 2025, 07:14

Remembering Amy Babler: A fearless Advocate for Cancer Awareness and Communications

Insight

Jan 16, 2025, 07:08

Predictive Oncology has Announced Agreement to be Acquired by Renovaro